Taros Chemicals celebrates 15 years It was the 15th jubilee celebration of the company and its 10th anniversary in the pharmaceutical hub of Dortmund’s Bio-Medicine Centre. Besides the official inauguration of an additional 500 square meters of high-tech laboratory space, Taros had many more reasons to celebrate on 28th February, 2014, when they were honoured […]
Taros Chemicals celebrates 15 years Read More »
Taros’ COO, Alexander Piechot, PhD, stated “OPTIBIOCAT is an exciting venture that involves highly skilled and multidisciplinary partners from 16 organizations in eight EU countries. Taros’ involvement will help to set up…
Taros Chemicals Selected to Partner in OPTIBIOCAT Project Read More »
Taros Chemicals GmbH & Co. KG, “Taros” announced the appointment of Prof. Dr. Herbert Waldmann and Prof. Dr. Axel Kleemann as Scientific Advisors to the Taros Management Board…
Taros announces appointment of two Scientific Advisors Read More »
Bernhard Rapkay, MdEP (SPD) visited Taros Chemicals Dortmund, 25.07.2013 ++++ Bernhard Rapkay, NRW MdEP for the SPD has been informed by Dr. Dimitrios Tzalis (founder & CEO)about the backgrounds of the unique EUR 196 million budgeted “Europen lead factory drug development platform (ELF)” during his stay at Dortmund based Taros Chemicals, the Leader of ELF’s Chemistry
Bernhard Rapkay, MdEP (SPD) visited Taros Chemicals Read More »
€196 million pan-european drug discovery platform launched Large pharmaceutical companies join forces with small and medium-sized enterprises (SMEs) and academia in an IMI-supported public private partnership (PPP) to enhance early drug discovery and so address the ever-increasing need for innovative therapeutics to tackle unmet medical needs. Taros Chemicals to lead the Chemistry Consortium within the
€196 million pan-european drug discovery platform launched Read More »
Content
Contact
Taros Chemicals GmbH & Co. KG
Emil-Figge-Str. 76a
44227 Dortmund
GERMANY
© 2022 Taros Chemicals GmbH & Co. KG. All rights reserved.
